MEDICINOVA INC (MNOV) Form 8-K Material Events
MEDICINOVA INC (MNOV) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MNOV
CIK: 1226616
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerScott Young
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-29 | 2026-09-25 | 4 Filing | 0001213900-26-104739 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-29 | — | SCHEDULE 13D/A Filing | 0001213900-26-104738 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-23 | 8-K | 0001193125-26-405318 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-08-31 | 8-K | 0001193125-26-379348 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-17 | 8-K | 0001193125-26-356146 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349323 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-23 | 4 Filing | 0001683168-26-005111 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-23 | 4 Filing | 0001683168-26-005110 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-23 | 4 Filing | 0001683168-26-005109 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-23 | 8-K | 0001193125-26-281171 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001193125-26-224066 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001193125-26-191932 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFA14A | 0001193125-26-191914 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-23 | DEF 14A | 0001193125-26-191866 | View SEC Doc Filr Page |
| PRER14A | 2026-04-20 | — | PRER14A | 0001193125-26-164217 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-17 | 2026-06-23 | PRE 14A | 0001193125-26-161734 | View SEC Doc Filr Page |
| 10-K | 2026-03-10 | 2025-12-31 | 10-K | 0001193125-26-100432 | View SEC Doc Filr Page |
| 8-K | 2026-02-20 | 2026-02-20 | 8-K | 0001193125-26-060232 | View SEC Doc Filr Page |
| 4 | 2026-01-20 | 2026-01-16 | 4 Filing | 0001683168-26-000430 | View SEC Doc Filr Page |
| 4 | 2026-01-20 | 2026-01-16 | 4 Filing | 0001683168-26-000428 | View SEC Doc Filr Page |
| 424B5 | 2025-12-30 | — | 424B5 | 0001193125-25-335918 | View SEC Doc Filr Page |
| 8-K | 2025-12-30 | 2025-12-29 | 8-K | 0001193125-25-335917 | View SEC Doc Filr Page |
| EFFECT | 2025-12-11 | — | EFFECT Filing | 9999999995-25-003685 | View SEC Doc Filr Page |
| CORRESP | 2025-12-09 | — | CORRESP Filing | 0001193125-25-312838 | View SEC Doc Filr Page |
| S-3 | 2025-12-05 | — | S-3 | 0001193125-25-309730 | View SEC Doc Filr Page |